Virtual Medicinal Product (VMP) - Bupivacaine liposomal 133mg/10ml prolonged-release dispersion for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Bupivacaine liposomal 133mg/10ml prolonged-release dispersion for injection vials | Start Date 01-10-2021 | End Date |
| Abbreviated Name | Abbreviated Name Bupivacaine liposomal 133mg/10ml prolonged-release inj vials | Start Date 01-10-2021 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 10.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Infiltration, Perineural
- Form
- Prolonged-release dispersion for injection
- Ontology Form/Route
- dispersioninjectionprolonged-release.infiltration, dispersioninjectionprolonged-release.perineural
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N01BB01
| Code | Start Date | End Date |
|---|---|---|
| 40163211000001101 | 01-10-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Bupivacaine liposomal | Based on Ingredient Substance | 13.3 mg | 1 ml |
Name
Bupivacaine liposomal
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
13.3
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMBupivacaine liposomal
-
VMP(Current) Bupivacaine liposomal 133mg/10ml pro...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 10 vial |